Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsPrior to the COVID-19 outbreak the medical community had pinned high hopes on efforts to tackle the prevalence of cervical cancer, which remains among the deadliest forms of the disease in the country despite it being the most preventable. However, the pandemic has disrupted mass screening and vaccination programs.
A vaccine given to girls to protect them against a virus that causes cervical cancer is a “critical” health tool and access to it should be scaled up as swiftly as possible, especially in poorer countries, cancer experts said on Monday.
The research by scientists at the respected scientific network the Cochrane Review also found no increase in the risk of serious side effects, with rates of around 7 percent reported by both HPV-vaccinated and control groups.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.